Prognostic Stage 2 Breast Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Abemaciclib (DB12001)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Active Not Recruiting1 IdentifierTitlePurposeDrugs
NCT04481113Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast CancerTreatment